No Data
No Data
Is Sirio Pharma Co., Ltd. (SZSE:300791) Worth CN¥23.1 Based On Its Intrinsic Value?
Sirio Pharma (300791.SZ): Vice President Yao Zhuangmin intends to increase his shareholding in the company by 3 million yuan to 5 million yuan.
On July 25th, Gelunhui reported that Mr. Yao Zhuangmin, Director and Vice President of Sirio Pharma (300791.SZ), plans to increase his shareholding in the company within six months from the date of this announcement (from July 26, 2024 to January 25, 2025) through the trading system of Shenzhen Stock Exchange in a manner permitted by relevant laws and regulations (including but not limited to centralized bidding and bulk trading), with an amount of no less than RMB 3 million and no more than RMB 5 million.
Sirio Pharma: 2024 Interim Performance Forecast
Sirio Pharma (300791.SZ): Vitamins and nutritional health food is one of the company's main products.
Sirio Pharma (300791.SZ) stated on its investor platform that vitamin-based nutritional health food is one of the company's main products. As of now, the company has multiple vitamin D-related products including Tianshan Vitamin D Softgel Capsules, Suyi Vitamin D Softgel Capsules, Vitamin D Calcium Softgel Capsules, and Calcium Magnesium Zinc Vitamin D Tablets.
Sirio Pharma (300791.SZ): Equity distribution in 2023 is 10 shares for every 3 shares and a dividend of 11 yuan per share. The record date for equity is June 20th.
Sirio Pharma (300791.SZ) announced on June 14th that the company's equity distribution plan for 2023 is as follows: based on a total share capital of 181,806,354 shares on the day of the announcement, after deducting 1,285,600 shares repurchased in the company's repurchase specialized securities account, the basic number of shares is 180,520,754, and RMB 11 yuan cash (tax included) will be paid for every 10 shares, and 3 shares will be transferred to all shareholders as capital reserves. The registration date for this equity distribution is on June 20, 2024, and the ex-rights and ex-dividend date is on June 21, 2024.
Sirio Pharma Co., Ltd.'s (SZSE:300791) Market Cap Dropped CN¥366m Last Week; Private Companies Bore the Brunt
No Data